|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL.: (2006.01) |
A61K 31/505 C07D 487/00 |
| (11) | Number of the document | 4680 |
| (13) | Kind of document | B |
| (21) | Application number | 99-008 |
| (22) | Date of filing the application | 1999-01-25 |
| (41) | Date of publication of the application | 2000-03-27 |
| (45) | Date of publication of patent | 2000-07-25 |
| (86) | Number | PCT/US97/13072 |
| Date | 1997-07-23 |
| (87) | Number | WO 98/03510 |
| Date | 1998-01-29 |
| (30) | Number | Date | Country code |
| 686047 | 1996-07-24 | US | |
| 023290 | 1996-07-24 | US | |
| 899242 | 1997-07-23 | US |
| (71) |
DUPONT PHARMACEUTICALS COMPANY,
1007 Market Street, Wilmington, DE 19898,
DE
|
| (72) |
Argyrios Georgios ARVANITIS, US
Robert John CHORVAT, US Paul Joseph GILLIGAN, US Liqi HE, US |
| (73) |
BRISTOL-MYERS SQUIBB PHARMA COMPANY,
Route 206 & Provinceline Road, Princeton, New Jersey 08543-4000,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | AZOLO TRIAZINES AND PYRIMIDINES |
| Payment date | Validity (years) | Amount | |
| 2016-06-27 | 20 | 347.00 EUR |
| Patent expired | ||
| Invalidation date | 2017-07-23 |